How Many Units of Tirzepatide Are in Each Mounjaro Dose?

Why the 'units' question matters, and where it comes from

A question our prescribers hear most weeks is some version of: "how many units is my dose?" It usually comes from people who have experience with insulin pens, where doses really are counted in units and dialled up individually. Tirzepatide works differently. The Mounjaro KwikPen is pre-filled and pre-set, you press the button, and a fixed volume containing the labelled milligram amount is delivered. There is no dial, no units counter, and nothing for you to calculate.

If you have seen a volume figure quoted (say, 0.5 ml) that is the standard injection volume across all Mounjaro strengths. The tirzepatide units guide on this site breaks down how concentration and volume relate to each strength, which is useful context if you are comparing pens or checking a prescription. For most people in clinical care, though, the number you need to know is simply the milligram strength on your pen's label.

The short answer: "units" in the traditional insulin sense do not translate to tirzepatide. What you track is the milligram strength your prescriber has prescribed.

The six strengths and what the dose ladder actually looks like

Treatment with tirzepatide starts at 2.5 mg. This is a tolerability dose, its job is to let your body adjust to the medicine before any meaningful dose increase, which is why it sits at the bottom of the schedule rather than producing large early changes. From 2.5 mg, doses increase in 2.5 mg steps, typically every four weeks: 2.5 → 5 → 7.5 → 10 → 12.5 → 15 mg. The 25 units, 50 units and 75 units pages cover the specific volume figures people sometimes encounter on clinic paperwork.

According to the BNF entry for tirzepatide, the maintenance range is 5–15 mg once weekly, with 15 mg being the maximum licensed dose in the UK. Not everyone titrates to 15 mg; your prescriber will assess the right stopping point based on how your body is responding and whether side effects are a factor.

Each KwikPen contains four doses at the same strength. You use it once a week, on the same day each week where possible, then start a new pen. You can read more about the full picture of how tirzepatide works on the Mounjaro treatment page.

How the volume per dose translates to what you inject

All Mounjaro KwikPen strengths are formulated to deliver 0.5 ml per injection. What changes between strengths is the concentration of tirzepatide dissolved in that volume: a 2.5 mg pen contains 5 mg/ml, a 5 mg pen 10 mg/ml, and so on up to the 15 mg pen at 30 mg/ml. This fixed-volume design means the injection experience feels broadly the same regardless of which strength you are on. There is no "more liquid" as the dose goes up.

If you have ever seen a reference to how many ml 50 units of tirzepatide is, that framing typically comes from compounded or non-UK formulations where the concentration varies and users do measure volume manually. In UK-licensed Mounjaro, that calculation is irrelevant: the pen handles it. This distinction matters because it is one reason the NHS and MHRA consistently warn against obtaining tirzepatide outside the licensed supply chain, where concentrations may differ from what is labelled.

For context on the wider landscape of Mounjaro costs and availability, the Eli Lilly UK price change page covers what happened to list prices from September 2025 and why that affects private prescriptions.

What determines the right dose for you

Dose is a clinical decision, full stop. The titration schedule in the SmPC gives prescribers a framework, but real-world decisions weigh several factors: how well you are tolerating the current dose, your response so far, any relevant medical history, and medicines you take alongside tirzepatide. Someone who is struggling with nausea at 5 mg might stay there longer before moving up. Someone who is tolerating it well and has a clinical reason to progress may move on schedule. Neither of those paths is wrong, they reflect prescribing tailored to the individual.

What this means practically: if you are unsure whether you are on the right dose, or if you are transferring from another service and want a clinical review of where you are in the titration, that conversation belongs with a prescriber. The NHS patient information for tirzepatide, available on the NHS medicines page for tirzepatide, is also a reliable reference for what to expect at each stage.

If you are exploring treatment for the first time, the weight-loss treatment overview sets out what is licensed in the UK and how the private route works. Ready to speak to a clinician about whether tirzepatide is right for you? Speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered Independent Prescriber.